First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 69.5% of the 24,457 shares held after it.
3 other insiders bought within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, E&S Lines Segment Sutherland Todd Randell bought about $99.8K of JRVR on Jun 2, 2025; 3 other insiders bought within 30 days and 70 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 47.2% of the 39,201 shares held after it.
3 other insiders bought within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Migliorato Peter B. bought about $101.0K of JRVR on May 20, 2025; 3 other insiders bought within 30 days and 70 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 47.9% of the 60,758 shares held after it.
3 other insiders bought within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director LaSala Christine bought about $152.3K of JRVR on May 19, 2025; 3 other insiders bought within 30 days and 70 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 3, 2022.
The trade is 24.0% of the 416,624 shares held after it.
3 other insiders bought within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer D'Orazio Frank bought about $475.0K of JRVR on May 15, 2025, the largest insider purchase at the company since 2022; 3 other insiders bought within 30 days and 70 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Mar 4, 2022.
+12.2% median (+12.2% mean) 90-day return after 2 previous buys.
The trade is 21.2% of the 9,439 shares held after it.
1 other insider bought within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Brown Thomas Lynn bought about $46.1K of JRVR on Nov 4, 2022; 1 other insider bought within 30 days and 70 funds added in the latest 13F quarter.
19 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
No insider has filed to sell. Watch this after a run-up.
JRVR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Boston Partners Small Cap Value Fund II
$2.3M position · as of 2026-05-31
0.3%
Ultra-Small Company Market Fund
$321.2K position · as of 2026-06-30
0.2%
NORTH SQUARE KENNEDY MICROCAP FUND
$55.5K position · as of 2026-05-31
0.2%
T. Rowe Price Small-Cap Value Fund, Inc.
$11.8M position · as of 2026-06-30
0.1%
Ultra-Small Company Fund
$110.0K position · as of 2026-06-30
0.1%
Meridian Contrarian Fund
$660.0K position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · DORAZIO
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2022
$3.1M
$2.9M
$1.6M
-45%
+10%
2021
$1.3M
$116.8K
$1.2M
-25%
+23%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows 70 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$653.2M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM JRVR
FY Dec 2025
$687.6M
FY Dec 2024
$707.6M
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
$772.9M
Jun 2026
$161.3M
Mar 2026
$151.4M
Dec 2025
$167.7M
Sep 2025
$172.7M
Jun 2025
$174.8M
Mar 2025
$172.3M
Dec 2024
$126.7M
Sep 2024
$191.5M
At each fiscal year end
Single quarter
Net margin, TTM
+4.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM JRVR
FY Dec 2025
+6.9%
FY Dec 2024
-11.5%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
-22.4%
Jun 2026
+4.0%
Mar 2026
-5.9%
Dec 2025
+19.1%
Sep 2025
+0.6%
Jun 2025
+2.7%
Mar 2025
+5.6%
Dec 2024
-51.1%
Sep 2024
-20.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM JRVR
FY Dec 2025
-$23.6M
FY Dec 2024
-$252.0M
FY Dec 2023
$81.5M
FY Dec 2022
$214.5M
FY Dec 2021
-$919.8M
Jun 2026
-$5.9M
Mar 2026
-$766.0K
Dec 2025
-$29.3M
Sep 2025
$33.7M
Jun 2025
$24.7M
Mar 2025
-$52.7M
Dec 2024
$4.7M
Sep 2024
-$270.8M
At each fiscal year end
Single quarter
Debt to equity
0.19x
long-term debt only, 2019-09-30 (82 months older than the period end); equity 2026-06-30
Debt to equity JRVR
FY Dec 2025
0.18x
FY Dec 2024
0.21x
FY Dec 2023
0.18x
FY Dec 2022
0.18x
FY Dec 2021
0.14x
Jun 2026
0.19x
Mar 2026
0.19x
Dec 2025
0.18x
Sep 2025
0.20x
Jun 2025
0.20x
Mar 2025
0.20x
Dec 2024
0.21x
Sep 2024
0.19x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.02x
TTM operating cash flow over long-term debt only, 2019-09-30 (82 months older than the period end)
Cash flow to debt JRVR
FY Dec 2025
-0.19x
FY Dec 2024
-2.51x
FY Dec 2023
0.89x
FY Dec 2022
2.27x
FY Dec 2021
-9.29x
Jun 2026
0.02x
Mar 2026
0.33x
Dec 2025
-0.19x
Sep 2025
0.16x
Jun 2025
-2.94x
Mar 2025
-3.28x
Dec 2024
-2.51x
Sep 2024
-2.69x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+6.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity JRVR
FY Dec 2025
+9.5%
FY Dec 2024
-16.3%
FY Dec 2023
n/a
FY Dec 2022
+4.8%
FY Dec 2021
-22.7%
Jun 2026
+6.0%
Mar 2026
+5.8%
Dec 2025
+9.5%
Sep 2025
-9.6%
Jun 2025
-17.4%
Mar 2025
-17.0%
Dec 2024
-16.3%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets JRVR
FY Dec 2025
+1.0%
FY Dec 2024
-1.6%
FY Dec 2023
n/a
FY Dec 2022
+0.6%
FY Dec 2021
-3.5%
Jun 2026
+0.6%
Mar 2026
+0.6%
Dec 2025
+1.0%
Sep 2025
-1.0%
Jun 2025
-1.8%
Mar 2025
-1.7%
Dec 2024
-1.6%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital JRVR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed JRVR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
8.93x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing JRVR
FY Dec 2025
8.05x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
35.44x
FY Dec 2021
n/a
Jun 2026
10.00x
Mar 2026
15.75x
Dec 2025
8.05x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$84.4M
market value at close 2026-10-26 on 2026-08-05 shares, plus long-term debt only, 2019-09-30 (82 months older than the period end), minus cash 2026-06-30
Enterprise value JRVR
FY Dec 2025
$129.7M
FY Dec 2024
-$79.8M
FY Dec 2023
$171.8M
FY Dec 2022
$722.4M
FY Dec 2021
$982.5M
Jun 2026
$106.2M
Mar 2026
$160.3M
Dec 2025
$129.7M
Sep 2025
$114.4M
Jun 2025
$147.2M
Mar 2025
$10.6M
Dec 2024
-$79.8M
Sep 2024
-$24.3M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-1.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield JRVR
FY Dec 2025
-8.1%
FY Dec 2024
-136.8%
FY Dec 2023
+23.4%
FY Dec 2022
+27.4%
FY Dec 2021
-85.6%
Jun 2026
-1.1%
Mar 2026
+9.8%
Dec 2025
-8.1%
Sep 2025
+4.1%
Jun 2025
-109.3%
Mar 2025
-171.1%
Dec 2024
-136.8%
Sep 2024
-113.7%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing JRVR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
JRVR ranks highest on financial health (42nd percentile) and risk and compliance (30th), and lowest on growth (11th), among Insurance peers.
Profitability
24
Inputs
Return on equity+6.0% · 21 pct, sector of 116
Return on assets+0.6% · 26 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
42
Inputs
Debt to equity0.19x · 70 pct, sector of 104
Cash flow to debt0.02x · 14 pct, sector of 97
Growth
11
Inputs
Revenue growth, YoY-2.8% · 11 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
28
Inputs
Funds adding, latest quarter70 · 28 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
30
Inputs
Short interest, % of float+4.0% · 42 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+17.5% · 18 pct, sector of 110
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
JRVR filings, in plain words
Read the full summary
1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 10.0% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.